Acuity now features enhanced site monitoring support, full tracking of insights into actions, and Japanese localization
Houston, TX - Algorics, a provider of cloud-based innovative clinical analytics solutions and software for the global life sciences industry, today announced the release of Acuity version 1.4.
Key features of the new release include:
Decision Factory – Site monitoring recommendation module
Action Center – End-to-end workflow within Acuity to track insights into actions
Localization & Japanese support
Nithiya Ananthakrishnan, CEO of Algorics commented, “Our customers and partners feedback has directly driven the development of the latest version of Acuity. We understand that clinical data analytics is not just dashboard reporting but the need for end-to-end workflow that transforms insights to decisions and actions. This eliminates the risk of losing track of actions that should be taken post data analysis."
Rob Nichols, CCO of Algorics added “The Japanese localization enables us to support our customers and industry partners with a presence in Japan. We look forward to building an increased presence in the region and demonstrating the new and enhanced features.”
Meet us in March 2017 and find out more about the Acuity analytics platform:
March 21-22
Outsourcing in Clinical Trials South East 2017 - Cary, NC, USA
Clinical Data Integration & Management - Princeton, NJ, USA
March 23-24
OmniComm Innovation Forum Europe 2017 - Barcelona, Spain
March 26-31
SQA Annual Meeting - National Harbor, ND, USA
March 29-31
DIA Euromeeting - Glasgow, UK
About Algorics
Algorics brings together a team of highly experienced software and life sciences professionals, united behind a single goal: to provide innovative clinical analytics solutions and software to the global life sciences industry
with consistent and reliable quality. Algorics has a truly international presence, with offices in Doylestown, PA, Houston, TX (USA), London (UK) and Bangalore (India). Learn more by visiting www.algorics.com or
stay updated by following us on social media: Twitter, Facebook, LinkedIn
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.
Pfizer Reports Strong Phase III Results for Hympavzi in Hemophilia Patients with Inhibitors
June 26th 2025The Phase III BASIS trial found that once-weekly subcutaneous Hympavzi reduced treated bleed rates by 93% in patients with hemophilia A or B with inhibitors, offering a promising new prophylactic option for a population with limited therapeutic choices.